Johnson & Johnson's Bispecific Antibodies for Atopic Dermatitis and Talks of Biotech ... - GeneOnline

Retrieved on: 2024-06-20 12:07:48

Tags for this article:

Type I hypersensitivity

Dermatitis

Click the tags to see associated articles and topics

Johnson & Johnson's Bispecific Antibodies for Atopic Dermatitis and Talks of Biotech ... - GeneOnline. View article details on hiswai:

Summary

The article discusses Johnson & Johnson's acquisition of Numab Therapeutics' bispecific antibody NM26 for atopic dermatitis treatment, highlighting their biotech partnerships and strategies discussed at the BIO 2024 convention. Bernice Lottering authored it. Tags and the key concept 'Biotech' are connected via the topics of atopic dermatitis, hypersensitivity, and collaborative efforts in the biotech industry.

Article found on: www.geneonline.com

View Original Article